Invex Therapeutics Ltd.ASX: IXC

Global Phase 3 Trial of Presendin to Launch in Q4 2021

Nov 4, 2021 at 2:33 AM UTC · Issued by Invex Therapeutics Ltd.

Invex Therapeutics Ltd has released a press release.

View Attachment